ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of Action, Supporting Its Potential to Increase Live Birth Rate Following Embryo Transfer in IVF September 3, 2019 - NASDAQ Companies 0 » View More News for September 03, 2019
